Berkshire Hathaway Inc (BERK34)
Sao Paulo Exchange · Brazil · prices in BRL · close of 22 Oct 2026
Key indicators
| Last close | BRL 138.35 |
|---|---|
| 52-week range | 114.15 – 140.34 |
| Return, 1 month / 3 months | +7.9% / +12.4% |
| Return, 1 year / 3 years | +4.0% / +63.7% |
| Trend | Uptrend |
| RSI (14) | 67 |
| Volatility (1 year) | 19.2% |
| Worst drawdown (1 year) | -18.0% |
| Average daily value traded | 5.95M BRL |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Berkshire Hathaway is an American holding company based in Omaha, Nebraska. It owns insurance businesses that write property, casualty and reinsurance policies, and it owns a broad collection of operating companies spanning freight rail, utilities and energy, manufacturing, building products, retail and services. Through its insurance and investment operations it also holds equity stakes in other publicly traded businesses. Its customers range from individuals and businesses buying insurance to the many buyers of its industrial, consumer and retail products.
Berkshire Hathaway Inc is represented on the Sao Paulo Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code BERK34, with its price quoted in Brazilian reais (BRL). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Berkshire Hathaway Inc (BERK34) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 138.35 on 22 October 2026.
Its price-based Market X-Ray is 76 out of 100 (a strong price profile), ranking 58 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 4.0% and over the last three months it rose 12.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 75 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 8.9% | ||
| From 52-week high | -0.8% | ||
| Momentum | 64 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 12.4% | ||
| 6-month return | 19.4% | ||
| 12-month return, skipping the last month | -3.6% | ||
| Stability (higher is calmer) | 85 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 19.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.0% | ||
| Liquidity | 84 · Strong | Trades actively. | |
| Average daily value traded | 5.95M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +2.6% |
|---|---|
| 1 month | +7.9% |
| 3 months | +12.4% |
| 6 months | +19.3% |
| 1 year | +4.0% |
| 3 years | +63.7% |
| 5 years | +69.2% |
Signals
| 50-day / 200-day average | 130.75 / 126.99 |
|---|---|
| Golden / death cross (60 days) | Golden, 47 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.28 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.